U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07632872) titled 'Desloratadine as Adjunct Therapy for Rheumatoid Arthritis' on May 28.
Brief Summary: Rheumatoid arthritis is a chronic inflammatory disease that causes joint pain, swelling, and reduced physical function. Although standard disease-modifying antirheumatic drugs are effective for many patients, some individuals continue to have active disease.
The purpose of this study is to evaluate the effectiveness and safety of adding desloratadine to standard therapy in patients with active rheumatoid arthritis. Participants will receive either desloratadine or placebo in addition to their usual treatment.
The study will assess changes in diseas...